Combining Gene Signatures Improves Prediction of Breast Cancer Survival-Reference-Cited by-同舟云学术

Combining Gene Signatures Improves Prediction of Breast Cancer Survival

Published:2011-03-10 Issue:3 Volume:6 Page:e17845
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhao Xi,Rødland Einar Andreas,Sørlie Therese,Naume Bjørn,Langerød Anita,Frigessi Arnoldo,Kristensen Vessela N.,Børresen-Dale Anne-Lise,Lingjærde Ole Christian

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.;T Sørlie;Proc Natl Acad Sci U S A,2001

2. A gene-expression signature as a predictor of survival in breast cancer.;MJ van de Vijver;N Engl J Med,2002

3. Gene expression profiling predicts clinical outcome of breast cancer.;LJ van 't Veer;Nature,2002

4. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.;C Sotiriou;J Natl Cancer Inst,2006

5. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.;HY Chang;PLoS Biol,2004

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy;Radiotherapy and Oncology;2022-06

2. Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature;PLOS ONE;2022

3. Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature;PLOS ONE;2022-02-10

4. Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy;Radiotherapy and Oncology;2022-02

5. Opposing Functions of BRD4 Isoforms in Breast Cancer;Molecular Cell;2020-06